Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors

European Journal of Pharmacology

Volumn 342, Issue 2-3, 1998, Pages 367-370

  Nowak, Gabriel ^a   Legutko, Beata ^a,b   Skolnick, Phil ^b   Popik, Piotr ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Adaptation; Chronic; Citalopram; Cortex; Fluoxetine; NMDA receptor

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DATA ANALYSIS; DEPRESSION; ELECTRIC SHOCK; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SEROTONIN BRAIN LEVEL;

2-AMINO-5-PHOSPHONOVALERATE; ADAPTATION, PHYSIOLOGICAL; ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; CITALOPRAM; EXCITATORY AMINO ACID ANTAGONISTS; FLUOXETINE; GLYCINE; MALE; MICE; RADIOLIGAND ASSAY; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN UPTAKE INHIBITORS;

EID: 0032567795     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01589-6     Document Type: Article

References (11)

1. Carter A.J. Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs Future. 17:1992;595-613.
2. Huang, N.-Y., Layer, R.T., Skolnick, P., 1997. Is an adaptation of NMDA receptors an obligatory step in antidepressant action? In: Skolnick, P. (Ed.), Antidepressants. New Pharmacological Strategies. Humana Press, Totowa, NJ, pp. 125-143.
3. Montgomery S.A. Efficacy in long-term treatment of depression. J. Clin. Psychiatry. 57 (Suppl. 2):1996;24-30.
4. 3H ]CGP-39653 binding by glycine in rat brain J. Neurochem. 61:1993;1492-1497.
5. Nowak G., Li Y., Paul I.A. Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol. 295:1996;75-85.
6. Nowak G., Trullas R., Layer R.T., Skolnick P., Paul I.A. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther. 265:1993;1380-1386.
7. Paul I.A., Layer R.T., Skolnick P., Nowak G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur. J. Pharmacol. Mol. Pharmacol. 247:1993;305-311.
8. Paul I.A., Nowak G., Layer R.T., Popik P., Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther. 269:1994;95-102.
9. Shader R.I., Fogelman S.M., Greenblatt D.J. Newer antidepressants: Further reflections. J. Clin. Psychopharmacol. 17:1997;75-77.
10. 3H ]CGP-39653: A new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain Eur. J. Pharmacol. 192:1991;19-24.
11. Skolnick P., Layer R.T., Popik P., Nowak G., Paul I.A., Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29:1996;23-26.